GRAEFF, Luisa Durán, Danila SEIDEL, Maria J. G. T. VEHRESCHILD, Axel HAMPRECHT, Anupma KINDO, Zdeněk RÁČIL, Judit DEMETER, Sybren De HOOG, Ute AURBACH, Maren ZIEGLER, Hilmar WISPLINGHOFF and Oliver A. CORNELY. Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry. Mycoses. Hoboken: Wiley-Blackwell, 2017, vol. 60, No 4, p. 273-279. ISSN 0933-7407. Available from: https://dx.doi.org/10.1111/myc.12595.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry
Authors GRAEFF, Luisa Durán (276 Germany), Danila SEIDEL (276 Germany), Maria J. G. T. VEHRESCHILD (276 Germany), Axel HAMPRECHT (276 Germany), Anupma KINDO (356 India), Zdeněk RÁČIL (203 Czech Republic, guarantor, belonging to the institution), Judit DEMETER (348 Hungary), Sybren De HOOG (528 Netherlands), Ute AURBACH (276 Germany), Maren ZIEGLER (276 Germany), Hilmar WISPLINGHOFF (276 Germany) and Oliver A. CORNELY (276 Germany).
Edition Mycoses, Hoboken, Wiley-Blackwell, 2017, 0933-7407.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30216 Dermatology and venereal diseases
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.793
RIV identification code RIV/00216224:14110/17:00096159
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1111/myc.12595
UT WoS 000395433700009
Keywords in English Geotrichum; invasive fungal diseases; Saprochaete
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 15/3/2018 16:33.
Abstract
Saprochaete and Geotrichum spp. are rare emerging fungi causing invasive fungal diseases in immunosuppressed patients and scarce evidence is available for treatment decisions. Among 505 cases of rare IFD from the FungiScope™ registry, we identified 23 cases of invasive infections caused by these fungi reported from 10 countries over a 12-year period. All cases were adults and previous chemotherapy with associated neutropenia was the most common co-morbidity. Fungaemia was confirmed in 14 (61%) cases and deep organ involvement included lungs, liver, spleen, central nervous system and kidneys. Fungi were S. capitata (n=14), S. clavata (n=5), G. candidum (n=2) and Geotrichum spp. (n=2). Susceptibility was tested in 16 (70%) isolates. All S. capitata and S. clavata isolates with the exception of one S. capitata (MIC 4 mg/L) isolate had MICs>32 mg/L for caspofungin. For micafungin and anidulafungin, MICs varied between 0.25 and >32 mg/L. One case was diagnosed postmortem, 22 patients received targeted treatment, with voriconazole as the most frequent first line drug. Overall mortality was 65% (n=15). Initial echinocandin treatment was associated with worse outcome at day 30 when compared to treatment with other antifungals (amphotericin B ± flucytosine, voriconazole, fluconazole and itraconazole) (P=.036). Echinocandins are not an option for these infections.
PrintDisplayed: 18/7/2024 22:26